Nuvectis Pharma, Inc.·4

Nov 6, 8:00 AM ET

Sanchez Juan 4

4 · Nuvectis Pharma, Inc. · Filed Nov 6, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
Sanchez Juan
Director
Transactions
  • Purchase

    Common Stock

    2025-11-05$5.79/sh+13,000$75,27078,150 total
Holdings
  • Common Stock

    (indirect: As custodian for son)
    415
Footnotes (1)
  • [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.77 to $5.81. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    tm2530379-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT